VIR NASDAQ
Vir Biotechnology, Inc.
1W: -0.7%
1M: -15.4%
3M: +19.4%
YTD: +52.0%
1Y: +90.9%
3Y: -63.7%
5Y: -78.6%
$9.19
+0.16 (+1.77%)
Weekly Expected Move ±6.8%
$8
$8
$9
$9
$10
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q1 2026281
Institutions Holding
+34 vs prior
75.0%
Ownership
+30.19%
63
New
107
Increased
87
Reduced
51
Closed
👔 Insider Trades
25 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-05-01 | SATO VICKI L | director | S-Sale | 22,000 | $10.05 | $221K | Filing |
| 2026-04-29 | De Backer Marianne | officer: president and ceo | J-J | 233,532 | $— | $0 | Filing |
| 2026-04-06 | De Backer Marianne | officer: president and ceo | S-Sale | 72,559 | $9.16 | $664K | Filing |
| 2026-04-01 | SATO VICKI L | director | S-Sale | 22,000 | $9.07 | $200K | Filing |
| 2026-03-20 | O'Byrne Jason | officer: evp & chief financial officer | J-J | 2,500 | $— | $0 | Filing |
| 2026-03-02 | SATO VICKI L | director | S-Sale | 200 | $9.98 | $2K | Filing |
| 2026-03-02 | SATO VICKI L | director | S-Sale | 21,800 | $9.50 | $207K | Filing |
| 2026-02-25 | Eisner Mark | officer: evp and chief medical officer | S-Sale | 1,889 | $9.82 | $19K | Filing |
| 2026-02-25 | de Verneuil Vanina | officer: evp, general counsel, corp sec | S-Sale | 13,700 | $9.82 | $135K | Filing |
| 2026-02-24 | O'Byrne Jason | officer: evp & chief financial officer | S-Sale | 1,634 | $9.53 | $16K | Filing |
| 2026-02-24 | SATO VICKI L | director | S-Sale | 42,177 | $9.75 | $411K | Filing |
| 2026-02-24 | SATO VICKI L | director | S-Sale | 200 | $10.26 | $2K | Filing |
| 2026-02-24 | De Backer Marianne | officer: chief executive officer | S-Sale | 14,762 | $9.53 | $141K | Filing |
| 2026-02-24 | Sabatini Brent | officer: svp, chief accounting officer | S-Sale | 1,430 | $9.53 | $14K | Filing |
| 2026-02-24 | de Verneuil Vanina | officer: evp, general counsel, corp sec | S-Sale | 3,117 | $9.53 | $30K | Filing |
| 2026-02-24 | Eisner Mark | officer: evp and chief medical officer | S-Sale | 1,616 | $9.53 | $15K | Filing |
| 2026-02-23 | O'Byrne Jason | officer: evp & chief financial officer | S-Sale | 2,089 | $7.45 | $16K | Filing |
| 2026-02-23 | Sabatini Brent | officer: svp, chief accounting officer | S-Sale | 1,829 | $7.45 | $14K | Filing |
| 2026-02-23 | de Verneuil Vanina | officer: evp, general counsel, corp sec | S-Sale | 4,445 | $7.45 | $33K | Filing |
| 2026-02-23 | Eisner Mark | officer: evp and chief medical officer | S-Sale | 2,089 | $7.45 | $16K | Filing |
| 2026-02-23 | De Backer Marianne | officer: chief executive officer | S-Sale | 19,039 | $7.45 | $142K | Filing |
| 2026-02-22 | Sabatini Brent | officer: svp, chief accounting officer | A-Grant/Award | 25,000 | $— | $0 | Filing |
| 2026-02-22 | de Verneuil Vanina | officer: evp, general counsel, corp sec | A-Grant/Award | 55,000 | $— | $0 | Filing |
| 2026-02-22 | Eisner Mark | officer: evp and chief medical officer | A-Grant/Award | 55,000 | $— | $0 | Filing |
| 2026-02-22 | De Backer Marianne | officer: chief executive officer | A-Grant/Award | 285,000 | $— | $0 | Filing |
🏛️ Congressional Trades
0 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| No congressional trades found | |||||
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| BlackRock, Inc. | 17,998,329 | $161M | +1,668,226 | 2026-03-31 | Filing |
| ARCH Venture Management, LLC | 12,916,663 | $116M | — | 2026-03-31 | Filing |
| SB INVESTMENT ADVISERS (UK) LTD | 10,948,093 | $98M | -2,168,884 | 2026-03-31 | Filing |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 9,215,577 | $83M | +9,215,577 | 2026-03-31 | Filing |
| GSK plc | 8,550,954 | $77M | — | 2026-03-31 | Filing |
| STATE STREET CORP | 7,141,094 | $64M | +911,539 | 2026-03-31 | Filing |
| VANGUARD CAPITAL MANAGEMENT LLC | 5,382,103 | $48M | +5,382,103 | 2026-03-31 | Filing |
| GOLDMAN SACHS GROUP INC | 3,250,227 | $29M | +1,681,323 | 2026-03-31 | Filing |
| ADAR1 Capital Management, LLC | 2,744,714 | $25M | +2,744,714 | 2026-03-31 | Filing |
| GEODE CAPITAL MANAGEMENT, LLC | 2,657,843 | $24M | +329,636 | 2026-03-31 | Filing |
| DIMENSIONAL FUND ADVISORS LP | 2,579,678 | $23M | +43,401 | 2026-03-31 | Filing |
| FMR LLC | 2,071,848 | $19M | -1,086,568 | 2026-03-31 | Filing |
| Soleus Capital Management, L.P. | 2,002,000 | $18M | +2,002,000 | 2026-03-31 | Filing |
| Point72 Asset Management, L.P. | 1,952,234 | $17M | +1,756,516 | 2026-03-31 | Filing |
| Boxer Capital Management, LLC | 1,866,000 | $17M | +1,241,000 | 2026-03-31 | Filing |
| GordonMD Global Investments LP | 1,518,552 | $14M | +588,235 | 2026-03-31 | Filing |
| Sio Capital Management, LLC | 1,498,620 | $13M | +1,020,277 | 2026-03-31 | Filing |
| Pictet Asset Management Holding SA | 1,480,828 | $13M | +1,467,340 | 2026-03-31 | Filing |
| Hudson Bay Capital Management LP | 1,469,510 | $13M | +144,510 | 2026-03-31 | Filing |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,442,336 | $13M | +1,442,336 | 2026-03-31 | Filing |